Research analysts at Needham & Company LLC assumed coverage on shares of Establishment Labs (NASDAQ:ESTA - Get Free Report) in a report released on Monday, Marketbeat Ratings reports. The brokerage set a "hold" rating on the stock.
Separately, Stephens reaffirmed an "overweight" rating and issued a $52.00 target price on shares of Establishment Labs in a research report on Thursday, March 6th. Two investment analysts have rated the stock with a hold rating and four have issued a buy rating to the company's stock. According to data from MarketBeat.com, Establishment Labs has a consensus rating of "Moderate Buy" and a consensus target price of $57.40.
View Our Latest Stock Report on ESTA
Establishment Labs Trading Up 4.2 %
Shares of NASDAQ ESTA traded up $1.27 during trading on Monday, hitting $31.45. 558,088 shares of the company were exchanged, compared to its average volume of 453,840. The company has a debt-to-equity ratio of 5.94, a quick ratio of 2.29 and a current ratio of 3.62. Establishment Labs has a 12-month low of $26.56 and a 12-month high of $60.12. The company has a fifty day moving average price of $36.56 and a 200-day moving average price of $39.72. The firm has a market capitalization of $907.21 million, a PE ratio of -12.19 and a beta of 0.77.
Establishment Labs (NASDAQ:ESTA - Get Free Report) last posted its quarterly earnings results on Wednesday, February 26th. The company reported ($0.98) earnings per share for the quarter, missing the consensus estimate of ($0.64) by ($0.34). The firm had revenue of $44.51 million during the quarter, compared to analysts' expectations of $44.45 million. Establishment Labs had a negative net margin of 46.13% and a negative return on equity of 184.55%. As a group, equities research analysts expect that Establishment Labs will post -2.41 EPS for the current year.
Institutional Investors Weigh In On Establishment Labs
Several hedge funds and other institutional investors have recently bought and sold shares of ESTA. Quarry LP acquired a new position in shares of Establishment Labs in the 4th quarter valued at $27,000. R Squared Ltd purchased a new position in Establishment Labs during the 4th quarter worth $36,000. Federated Hermes Inc. increased its stake in Establishment Labs by 3.0% in the fourth quarter. Federated Hermes Inc. now owns 32,720 shares of the company's stock valued at $1,507,000 after purchasing an additional 953 shares during the period. Swiss National Bank boosted its stake in shares of Establishment Labs by 2.7% during the fourth quarter. Swiss National Bank now owns 38,500 shares of the company's stock worth $1,774,000 after buying an additional 1,000 shares during the period. Finally, Handelsbanken Fonder AB grew its holdings in shares of Establishment Labs by 32.3% during the fourth quarter. Handelsbanken Fonder AB now owns 8,200 shares of the company's stock worth $378,000 after buying an additional 2,000 shares during the last quarter. 72.91% of the stock is currently owned by institutional investors and hedge funds.
About Establishment Labs
(
Get Free Report)
Establishment Labs Holdings Inc, a medical technology company, manufactures and markets medical devices for aesthetic and reconstructive plastic surgery. The company primarily offers silicone gel-filled breast implants under the Motiva Implants brand. It also provides Motiva Ergonomix and Motiva Ergonomix2 gravity sensitive round soft silicone-gel-filled breast implants; and Motiva Flora Tissue Expander, a breast tissue expander.
See Also
Before you consider Establishment Labs, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Establishment Labs wasn't on the list.
While Establishment Labs currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Nuclear energy stocks are roaring. It's the hottest energy sector of the year. Cameco Corp, Paladin Energy, and BWX Technologies were all up more than 40% in 2024. The biggest market moves could still be ahead of us, and there are seven nuclear energy stocks that could rise much higher in the next several months. To unlock these tickers, enter your email address below.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
